Synthetic biology of multicellular systems: new platforms and applications for animal cells and organisms.
نویسندگان
چکیده
Applications for Animal Cells and Organisms L life itself, synthetic biology began with unicellular organisms. Early synthetic biologists built genetic circuits in model prokaryotes and yeast because of their relative biological simplicity and ease of genetic manipulation. With superior genetic tools, faster generation times, and betterunderstood endogenous gene expression machinery, prokaryotes and yeast were (and remain) appealing hosts for the engineering of synthetic systems. Now in its second decade, synthetic biology in unicellular organisms has produced myriad synthetic genetic circuits, a number of industrial applications, and fundamental new biological insights unlikely to have emerged from nonsynthetic approaches. Yet, the biological complexity that made metazoans less attractive for early synthetic biology is precisely what makes these organisms exciting targets for a new generation. Multicellular phenomena such as development (with its linkage of growth, morphogenesis, and differentiation) seem dauntingly complex and have thus far evaded comprehensive understanding through biological approaches that rely on perturbations to natural systems. Synthetic approaches based on bottom-up reconstitution of these phenomena promise intimate insights, complementary to those obtained through traditional methods. At the same time, therapeutic applications of synthetic biology will have to function within, and ideally exploit, the many complex aspects of multicellular systems. For all these reasons, synthetic biology of animal cells has become an exciting, albeit challenging, frontier. Today, engineering animal cells remains primitive, based on slow, imprecise, and generally clunky tools. How will we reach the point where we can routinely design, build, and analyze synthetic genetic circuits that operate within the inherently multicellular contexts of developing embryos and mature tissues? There is some hope: major new advances in DNA synthesis and assembly enable construction of increasingly elaborate DNA constructs. New tools for genome targeting, particularly site-specific recombinases and programmable systems such as CRISPRs and TALEs, greatly improve our control of genome editing. Yet major technical challenges remain. The predictability and tunability of synthetic genetic elements remain poor. We often lack general strategies for isolating synthetic systems from the host cell and from each other. Locus-specific effects and cloneto-clone variation often limit systematic studies that require comparisons among different genotypes. Beyond these problems of implementation, our molecular toolbox remains limited. We do not have many regulatable transcription factors that work well in mammalian cells. We have few orthogonal signaling components that can link arbitrary intracellular pathways and enable cells to coordinate with one another in a controlled fashion; we also lack general and robust methods for integration of synthetic systems with the natural machinery of their hosts. At the end of the day, the time it takes to go from in silico design to stable cell lines containing full circuits, let alone whole animals, remains painfully long. In short, we need to better understand the components we do have, grow the number of components in our toolbox, tackle site-specific effects and reduce integration site variability, and speed the entire process up by an order of magnitude. Such advances will help us to tackle what is perhaps the biggest problem of all our lack of understanding of fundamental circuit design principles. Those principles will emerge only through construction and rigorous analysis of new synthetic circuits, enabled by new technologies and an expanding synthetic biology community. In this issue, we bring together four papers that bring the dream of synthetic multicellular biology closer. First, in order to increase the repertoire of regulatory components available, Stanton et al. identify homologues of the popular TetR repressor that target orthogonal binding sites; as with TetR, variants of these homologues can be deployed as repressors or activators in vivo. The activity of one such homologue, PhlF, can be controlled by the small molecule DAPG, analogously to the control of TetR by doxycycline, thus introducing a muchneeded new inducible system for mammalian synthetic biology. While new transcription factors are of great utility, coupling their activity to synthetic or natural environmental cues remains a major challenge for the field. Daringer et al. address this issue by developing a Modular Extracellular Sensor Architecture (MESA) that couples programmable detection of extracellular ligands to the induction of reporter gene expression through controlled protease recruitment, similarly to the Tango method previously demonstrated for detecting ligands of G-protein coupled receptors, receptor tyrosine kinases, and steroid hormone receptors. MESA entails construction of two synthetic transmembrane fusion proteins with conditionally dimerizing extracellular sensor domains and an intracellular domain that is either a protease or a transcription factor with a linker that contains a protease recognition site; dimerization of the sensor domains brings the protease in proximity to the transcription factor domain, which it then cleaves off of the fusion protein, releasing it for transit to the nucleus. Alternatively, the two transmembrane proteins can carry separate Nand C-terminal domains of the protease, with dimerization reconstituting protease activity that releases a transcription factor tethered to a third transmembrane protein. The MESA system opens up new possibilities for creating synthetic intercellular signaling circuits in mammalian cells. A third paper addresses some of the key challenges of genomic integration of synthetic circuits. We need the ability to stably integrate constructs into precisely defined sites, subject to minimal interference from the host genome. Human artificial chromosomes (HACs) represent promising vectors for constructing complex genetic circuits because they are stably
منابع مشابه
Ethical Debates on Synthetic Biology
Background: As an emerging interdisciplinary area of science with a multitude of potential facilities and applications, synthetic biology integrates different disciplines with one another ranging from basic science to engineering. This interdisciplinary branch therefore encompasses sciences that require specific development and ethical approaches. Materials and Methods: Science management princ...
متن کاملNew Platforms For Drug Screening And Toxicology: Necessity Or Need?
The liver is the largest internal organ in the human body that is responsible for more than 500 vital functions, including biosynthesis of major plasma proteins, immunity against infectious pathogens, balancing energy metabolism and xenobiotics biotransformation (1). One of the main functions of the liver is an important role in drug metabolism (2). Since developing new drug compounds into mark...
متن کاملFipronil: mechanisms of action on various organisms and future relevance for animal models studies
Because insects had developed resistance to several insecticides, today, neonicotinoids and fiproles are used to combat pests. The difference between this two classes of insecticides is that fipronil acts by inhibiting the receptors of nervous cells, while neonicotinoids perturbs the neuronal transmission. The suitable properties of fipronil make that its use to be more obvious on the pesticide...
متن کاملDesign and development of CAR-T cells for cancer therapy
Introduction: Today, treatment with CAR-T cells is accepted as an effective treatment for blood malignancies. CAR-T cells are autologous T cells that are engineered by gene transfer techniques to express a chimeric antigen receptor (CAR). Despite the promising results and the approval of six CAR-T cell products; these products have not yet been approved for solid tumors. In addition, the high c...
متن کاملApplications of Small Molecules in Muscle Tissue Engineering
Introduction: Skeletal muscles account for about 40% of the total body weight. Every year, hundreds of people lose at least part of their muscle tissue due to illness, war, and accidents. This can lead to disruption of activities such as breathing, movement, and social life. To this end, various therapeutic strategies such as medication therapy, cell therapy and tissue transplantation have been...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- ACS synthetic biology
دوره 3 12 شماره
صفحات -
تاریخ انتشار 2014